farmaco semaglutide 1.75mg Semaglutide GLP-1 Receptor Agonist Research

Semaglutide is a medication used in the treatment of type 2 diabetes mellitus, obesity, and other related conditions

If you're taking semaglutide and planning pregnancy or discover you're pregnant, stopping the medication and consulting your doctor immediately is essential

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

The results of the drug are comparable to what is seen with bariatric surgery, according to Eli Lilly.

Lose weight effectively in Katy, TX with GLP-1 treatment